Pharma

Your Article Summary

See Latest Articles

Update on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 08/17/09

Chugai Pharmaceutical Co., Ltd. and F. Hoffmann–La Roche Ltd. announced that FDA has accepted the complete response resubmission that Roche made to the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for Actemra the humanized anti–human IL–6 receptor monoclonal antibody, following the receipt of the Complete Response Letter in September 2008.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09

 See all of Drug/Product Approvals

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Freeze-Thaw Performance and Robustness Assessment of Celsius FFT 6L
BioPharm, 12/09/09

Bivariate Random Effects Meta-Analysis of Diagnostic Studies Using Generalized Linear Mixed Models
Medical Decision Making, 12/09/09

The Impact of Disposables on Project Economics in a New Antibody Plant
BioPharm, 12/09/09

 See all of Research & Development